Evidence map›Paper›PMID 28130403›Full record

ArticleThe Journal of experimental medicine2017

Suppression of lethal autoimmunity by regulatory T cells with a single TCR specificity.

Andrew G Levine, Saskia Hemmers, Antonio P Baptista, Michail Schizas, Mehlika B Faire, Bruno Moltedo, Catherine Konopacki, Marc Schmidt-Supprian, Ronald N Germain, Piper M Treuting and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. T Cell Thoughts.Immunological reviews · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Andrew G LevineHoward Hughes Medical Institute, Immunology Program, Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.ORCID 0000-0003-3717-7558
Saskia HemmersHoward Hughes Medical Institute, Immunology Program, Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.
Antonio P BaptistaLymphocyte Biology Section, Laboratory of Systems Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.ORCID 0000-0001-8182-8982
Michail SchizasHoward Hughes Medical Institute, Immunology Program, Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.
Mehlika B FaireHoward Hughes Medical Institute, Immunology Program, Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.
Bruno MoltedoHoward Hughes Medical Institute, Immunology Program, Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.ORCID 0000-0002-9150-863X
Catherine KonopackiHoward Hughes Medical Institute, Immunology Program, Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.
Marc Schmidt-SupprianHematology and Oncology, Klinikum rechts der Isar, Technische Universität München, 80333 Munich, Germany.
Ronald N GermainLymphocyte Biology Section, Laboratory of Systems Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
Piper M TreutingDepartment of Comparative Medicine, University of Washington School of Medicine, Seattle, WA 98195.ORCID 0000-0002-1812-1519
Alexander Y RudenskyHoward Hughes Medical Institute, Immunology Program, Ludwig Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065 rudenska@mskcc.org.
Memorial Sloan Kettering Cancer Center · USNational Institutes of Health · USTUM Klinikum · DEUniversity of Washington · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Multiscale Analysis of Immune ResponsesZIAAI000545 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GERMAIN, RONALD N · 2009 to 2025
$29.4M
Self Peptides Bound to MHC Class II In T Cell SelectionR37AI034206 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI RUDENSKY, ALEXANDER Y · 2009 to 2018
$4.8M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA008748NIAID NIH HHS R37 AI034206NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

The regulatory T cell (T reg cell) T cell receptor (TCR) repertoire is highly diverse and skewed toward recognition of self-antigens. TCR expression by T reg cells is continuously required for maintenance of immune tolerance and for a major part of their characteristic gene expression signature; however, it remains unknown to what degree diverse TCR-mediated interactions with cognate self-antigens are required for these processes. In this study, by experimentally switching the T reg cell TCR repertoire to a single T reg cell TCR, we demonstrate that T reg cell function and gene expression can be partially uncoupled from TCR diversity. An induced switch of the T reg cell TCR repertoire to a random repertoire also preserved, albeit to a limited degree, the ability to suppress lymphadenopathy and T helper cell type 2 activation. At the same time, these perturbations of the T reg cell TCR repertoire led to marked immune cell activation, tissue inflammation, and an ultimately severe autoimmunity, indicating the importance of diversity and specificity for optimal T reg cell function.

Indexed as

AutoimmunityT-Cell Antigen Receptor SpecificityAnimalsForkhead Transcription FactorsLymph NodesLymphocyte ActivationMiceReceptors, Antigen, T-CellT-Lymphocytes, RegulatoryForkhead Transcription FactorsFoxp3 protein, mouseReceptors, Antigen, T-Cell

Identifiers

PMID28130403
PMCPMC5339675
OpenAlexW2582566619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.